Risk factor | Author | Risk ratio/Hazard ratio | Stage and Measurement |
---|---|---|---|
1. Arm Lymphedema | |||
BMI > 25 Age > 60 Number of metastatic LNs Having a Breast/Chest-wall RT Having Axillary RT Lumpectomya | (KİBar, Aras et al. 2015) [27] | 5.911 (OR1.698–20.583) 3.680 (OR1.076–12.583) 1.115 (OR1.043–1.192) 3.249 (OR1.742–6.060) 4.375 (OR1.439–13.306) 0.294 (OR0.062–1.402)a | Patients undergoing Level III Mastectomy/ Lumpectomy/ Chemotherapy/ Radiotherapy Arm circumference measurement |
Having mastectomy (ALND) + RT | (Ozcinar, Guler et al. 2012) [29] | Patients with ALND + RT had statistically increased rate of lymphedema than patients with ALND and without RT (p = 0.030) | Stage I, II who underwent mastectomy Arm circumference measurement |
BMI > 25 Axillary Radiotherapy Stage of the cancer (I-III) | (Ozaslan and Kuru 2004) [30] | 5.55 (RR2.28–13.51) 2.75 (RR1.48–5.08) Not significant | Stage I-III Arm circumference measurement |
Number of lymph node removed 16–25 Removal > 25 Adjuvant RT + LND Chemotherapy | (Rebegea, Firescu et al. 2015) [21] | 1.85 (OR1.27–2.71) 4.88 (OR2.25–10.58) 3.87 (OR1.39–6.51) 1.45 (OR1.12–2.24) | Stages I-IV Arm circumference measurement |
Presence of seroma after breast cancer surgery Staging of cancera Time after surgery | (Paiva, Rodrigues et al. 2013) [34] | 2.71(PR1.49–4.91) 1.15(PR0.78–2.92)a Surgery for > 5 years is 9.7 times higher frequency than < 5 years | Women undergoing oncology follow up Perimetry |
Staging (Locally advanced III)a Post RT skin necrosis | (Khanna, Gupta et al. 2019) [41] | 2.21(OR 0.54–9.04)a 4.34 (OR1.07–17.65) | Early and locally advanced stages Arm circumference measurement |
Higher BMI Increasing number of lymph nodes dissected Higher nodal ratio Regional Lymph Node Radiation (RLNR) | (Rastogi, Jain et al. 2018) [42] | 1.191 (HR0.809–1.755) 1.445 (HR1.116–1.872) 1.135 (HR1.037–1.243) 1.020 (HR0.042–24.571) | Stage II – III Arm circumference measurement |
Axillary RT Presence of co-morbid condition | (Deo, Ray et al. 2004) [45] | 0.0709 (HR2.3222–7.1601) 0.1593 (HR1.1441–2.9369) | Stage I-III Arm circumference measurement |
Engaging in moderate to severe physical activity BMI of ≥25 Invasiveness of the tumor Modified Radical Mastectomy Having radiotherapy Past history of limb damage Number of lymph nodes removed | (Honarvar, Sayar et al. 2016) [47] | 14.0 (OR2.6–73.3) 4.2 (OR2.0–8.7) 13.7 (OR7.3–25.6) 4.3 (OR2.3–7.9) 3.9 (OR1.8–8.2) 1.7 (OR0.9–3.1) 1.1 (OR1.0–1.1) | Women with breast cancer Arm circumference measurement |
BMI | (Ay, Kutun et al. 2014) [28] | BMI of 25–29.9 was 1.445 times more likely to develop lymphoedema than a patient with a BMI of < 17.9 (p < 0.001), and a patient with a BMI of 30–34.9 was 6.643 times more likely to develop it than a patient with a BMI of < 17.9 (p < 0.001). | Stage I & II Arm circumference measurement |
2. Leg Lymphedema | |||
Age BMI Staginga | (de Melo Ferreira, de Figueiredo et al. 2012) [49] | 1.09 (OR1.00–1.18) 1.34 (OR1.01–1.77) 0.33 (OR0.02–5.33)a | Stage I-IV Clinical diagnosis |